8BioMed, a biotech company that develops hemoglobin-based oxygen carriers refined from bovine blood, is launching 8HUB, a 23,000-square-foot incubator in Malvern…
After more than two months of negotiations, Royal Philips reached an agreement to acquire BioTelemetry, a Malvern-based medical device developer, last month in a…
Chesterbrook-based AmerisourceBergen is continuing its international expansion with the acquisition of the Walgreens Boots Alliance’s overseas drug distribution business, writes Joseph DiStefano for…
The decision to expand beyond gene therapy and sign a deal to co-develop a COVID-19 vaccine has turned out well for Malvern-based…
Malvern-based Ocugen saw its stock nearly triple last week after the company signed a letter of intent with Bharat Biotech to co-develop the…
Royal Philips will buy Malvern-based BioTelemetry in a stock deal valued at $2.8 billion, writes John George for the Philadelphia Business Journal.
BioTelemetry…
Malvern-based Recro Pharma has named David Enloe its new president and CEO, writes John George for the Philadelphia Business Journal.
Enloe replaces the company…
Endo International, the Dublin-based pharmaceutical company with its U.S. headquarters in Malvern, has announced plans to restructure the company and eliminate 560 jobs…
Malvern-based Endo Pharmaceuticals has agreed to acquire BioSpecifics Technologies, a 20-year-old company based in Wilmington, for around $658 million, writes Joseph DiStefano…
Immunome, an Exton-based biopharmaceutical company, went public last week and managed to raise $39 million through an upsized initial public stock offering, writes John…
